ExxPharma has proprietary synchronized, multibarrier, abuse deterrent technology platforms that utilize innovative formulation & process designs to prevent all methods of dosage form tampering and potentially prevent or reduce all modes of drug abuse. The technology does not include potentially harmful aversive agents or antagonists in the dosage form, although the technology also permits the inclusion of these agents, if necessary. Products developed using the technology are expected to be granted ADF labeling by FDA.
• The technology platforms prevent dosage form tampering and abuse
• chewing/crushing followed by swallowing
• milling followed by snorting
• extraction followed by injection
• heating followed by smoking